Charles H. Paul

About

Charles H. Paul is President of CHP Consulting LLC, a regulatory compliance, operational excellence, training, and technical documentation consulting firm supporting pharmaceutical, biotechnology, medical device, and advanced therapy organizations worldwide. With more than 30 years of experience in regulated manufacturing environments, Charles specializes in helping organizations build sustainable quality systems that support compliance, operational performance, workforce effectiveness, and inspection readiness. His experience includes GMP quality systems, manufacturing operations, technical training development, process validation, deviation management, CAPA systems, operational excellence, documentation systems, and regulatory inspection preparation. Charles has supported organizations implementing new technologies, expanding manufacturing operations, establishing quality infrastructures, and preparing for complex regulatory inspections. He is a recognized author, speaker, and consultant who has delivered numerous webinars and seminars on GMP compliance, quality systems, human performance improvement, technical documentation, inspection readiness, and operational excellence throughout the life sciences industry.

Credentials

• 30+ Years Regulatory Consulting
• Advanced Therapy GMP Specialist
• SOP & Documentation Expert
• Life Sciences Trainer & Author

Topics Taught on EduCraft

• ChatGPT-Assisted Technical Writing
• Deviation Backlog Reduction: Balancing Investigation Depth, Closure Speed, and Justifiable Decisions
• Using EU GMP Annex 22 as the Framework for Governing AI Systems, Validation Traceability, and Data Integrity Controls
• Advanced Therapy GMP Release and Chain-of-Identity Controls
• AI for CAPA and Investigations: Where It Helps and Where It Can Get You in Trouble
• ChatGPT and AI-Powered Project Management — Revolutionize Your Projects Now
• Human Error and Documentation Practices in Good Laboratory Practices (GLP)
• Drug Master Files (DMFs) — Understanding and Meeting Your Global Regulatory and Processing Responsibilities
• GMP 101 and Inspection Readiness
• Data Integrity and Documentation Excellence
• Contamination Prevention and Environmental Control
• Deviations, CAPA and Change Control
• Inspection Close-Out, Enforcement Risk, and Long-Term FDA Relationship Management
• Human Behavior Under FDA Scrutiny: How Words, Actions, and Reactions Shape Inspection Outcomes
• Good Clinical Practices (GCP) Audit and Inspection Readiness
• FDA Inspection Readiness: Building a Defensible State of Control Before the Investigator Arrives
• ChatGPT-Assisted Technical WritingWednesday, June 24, 2026
• Deviation Backlog Reduction: Balancing Investigation Depth, Closure Speed, and Justifiable DecisionsThursday, August 27, 2026
• AI for CAPA and Investigations: Where It Helps and Where It Can Get You in TroubleMonday, July 13, 2026
• Advanced Therapy GMP Release and Chain-of-Identity ControlsTuesday, July 28, 2026
• Using EU GMP Annex 22 as the Framework for Governing AI Systems, Validation Traceability, and Data Integrity ControlsMonday, August 24, 2026